← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 1996Last known activity
Dec 31, 2025
Timeline
1910s
- Jan 1, 1911
Herbert Irving Comprehensive Cancer Center— Founded
Drugs by trial phase (87 distinct, 55 trials)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (49 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Amyloidosis
- Arthralgia
- Astrocytoma
- Basal Cell Nevus Syndrome
- Breast Diseases
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Transitional Cell
- Cardiotoxicity
- Central Nervous System Neoplasms
- Colorectal Neoplasms
- Drug-Related Side Effects and Adverse Reactions
- Endometrial Neoplasms
- Ependymoma
- Fallopian Tube Neoplasms
- Glioma
- Hodgkin Disease
- Hypercalcemia
- Immunoglobulin Light-chain Amyloidosis
- Kidney Neoplasms
- Leiomyosarcoma
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lung Neoplasms
- Lymphoma
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Neuroblastoma
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Neurotoxicity Syndromes
- Oligodendroglioma
- Osteoporosis
- Ovarian Neoplasms
- Peripheral Nervous System Diseases
- Plasmacytoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Sarcoma
- Skin Neoplasms
- Syndrome
- Tetanus
- Ureteral Neoplasms
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
Recent trials (50)
- NCT07049055CollaboratorPhase 1/Phase 2Dec 31, 2025
- NCT06364267CollaboratorPhase 2Sep 1, 2024
- NCT03304080CollaboratorPhase 1/Phase 2Dec 20, 2017
- NCT01385137Study chairPhase 3Feb 1, 2012
- NCT00885326Overall official - principal investigatorPhase 1Dec 1, 2009
- NCT00301886Study chairPhase 3May 1, 2006
- NCT00354302Study chairPhase 3Apr 1, 2006
- NCT00334932Lead sponsorPhase 1/Phase 2Feb 1, 2006
- NCT00334932Overall official - principal investigatorPhase 1/Phase 2Feb 1, 2006
- NCT00233961Study chairPhase 1Jan 1, 2005
- NCT00114166Study chairPhase 2Jan 1, 2005
- NCT00233961Lead sponsorPhase 1Jan 1, 2005
- NCT00365768Overall official - principal investigatorPhase 2Oct 1, 2004
- NCT00489086Overall official - principal investigatorPhase 2Jul 1, 2004
- NCT00783965Overall official - principal investigatorPhase 2Jul 1, 2004
Details
- Founded
- New York City, NY, US Jan 1, 1911
- Last known activity
- Dec 31, 2025